2nd Quarter - Termination
THE MCMANUS GROUP for IVX HEALTH
Firm
Client
Income
$40,000
Expenses
—
Terminated
Jun 30, 2020
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 14, 2020 | $40,000 | Replaced |
| 2nd Quarter - Termination (this page) | Sep 4, 2020 | $40,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Inclusion of COBRA subsidy in coronavirus relief legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Medicare/Medicaid MMM
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. International Pricing Index model (83 FR 54546). Supervision requirements in CMS-1744-IFC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| WILLIAM RHYNE | — |
Health Issues HCR
Distribution changes in the private market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRYAN CRONAN | — |
| JOHN MCMANUS | — |
| WILLIAM RHYNE | — |
| ALANNA TEMME | LD, Rep. Jon Porter. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.